Senseonics Holdings, Inc. (SENS) Stock
Fundamentals
Source: third-party data provider, as of October 12, 2026
Compare with SENS
Recent news

Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
SENS

Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
SENS

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
SENS

Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?
SENS
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 43.65
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- 0.34
- MACD histogram
- -0.19
- SMA 50
- $8.80
- Price above SMA 50
- EMA 50
- $8.80
- Price above EMA 50
- SMA 200
- $7.05
- Price above SMA 200
- EMA 200
- $7.49
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 2 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of -$0.54 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
SENS

Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
SENS

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
SENS

Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?
SENS

Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership
SENS

Senseonics Holdings, Inc. Common Stock Q1 Earnings Call Highlights
Senseonics Holdings, Inc. Common Stock Q1 Earnings Call Highlights
SENS

Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates
Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates
SENS

The $5 Signal: Why Senseonics’ Capital Raise Is Dragging SENS Stock Down
The $5 Signal: Why Senseonics’ Capital Raise Is Dragging SENS Stock Down
SENS

SENS Launches Eversense 365, World's Only One-Year CGM in Europe
SENS Launches Eversense 365, World's Only One-Year CGM in Europe
SENS

Senseonics Reports Strong One-Year Real-World Data for Eversense 365
Senseonics Reports Strong One-Year Real-World Data for Eversense 365
SENS
News tone: automated (AI) classification of the article's content, not a price prediction.
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Timothy T. Goodnow Ph.D. | President, CEO & Director | 1962 |
| Mr. Frederick T. Sullivan CPA | CFO, Secretary & Treasurer | 1982 |
| Dr. Mukul Jain Ph.D. | Chief Operating Officer | 1973 |
| Dr. Francine Ratner Kaufman M.D. | Chief Medical Officer & Director | 1951 |
| Mr. Brian B. Hansen | Chief Commercial Officer & Director | 1968 |
| Mr. Kenneth L. Horton J.D. | General Counsel & Corporate Development Advisor | 1967 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 12, 2026
Technical indicators
- RSI 14
- 43.65
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- 0.34
- MACD histogram
- -0.19
- SMA 50
- $8.80
- Price above SMA 50
- EMA 50
- $8.80
- Price above EMA 50
- SMA 200
- $7.05
- Price above SMA 200
- EMA 200
- $7.49
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $10.00
- Average
- $14.00
- High
- $18.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +4.2 | -15.8 | -6.3 | |||||||||
| 2022 | -2.5 | -33.3 | +11.3 | -27.8 | -18.9 | -10.4 | +26.5 | +40.2 | -25.4 | -9.9 | -9.8 | -11.2 |
| 2023 | +9.7 | -10.3 | -29.0 | -6.6 | +5.8 | +19.8 | +14.3 | -42.9 | +7.2 | -11.8 | +20.4 | -10.9 |
| 2024 | +0.4 | +25.2 | -15.5 | -7.0 | -7.0 | -2.7 | +7.1 | -3.7 | -6.6 | +0.4 | -8.2 | +68.1 |
| 2025 | +103.2 | -5.0 | -24.6 | +12.0 | -27.6 | -10.1 | +2.0 | -6.0 | -3.8 | -14.6 | -10.2 | -8.3 |
| 2026 | +24.4 | +14.1 | -20.0 | -0.6 | +33.1 | -17.0 | -6.2 | +76.5 | +8.4 | -9.8 |



